Comparative Efficacy of Whole-Brain Radiotherapy Combined with EGFR-TKI vs. EGFR-TKI Monotherapy in EGFR-Mutant NSCLC with Leptomeningeal Metastasis
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e12-e13
DOI: 10.1016/j.ijrobp.2026.06.682 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von X. Cao und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cao, X., & Zheng, X. (2026). Comparative Efficacy of Whole-Brain Radiotherapy Combined with EGFR-TKI vs. EGFR-TKI Monotherapy in EGFR-Mutant NSCLC with Leptomeningeal Metastasis. International Journal of Radiation Oncology*Biology*Physics, 126(1), e12-e13. https://doi.org/10.1016/j.ijrobp.2026.06.682
Vancouver
Cao X, Zheng X. Comparative Efficacy of Whole-Brain Radiotherapy Combined with EGFR-TKI vs. EGFR-TKI Monotherapy in EGFR-Mutant NSCLC with Leptomeningeal Metastasis. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e12-e13. doi:10.1016/j.ijrobp.2026.06.682
BibTeX
@article{Cao2026,
author = {Cao, X. and Zheng, X.},
title = {Comparative Efficacy of Whole-Brain Radiotherapy Combined with EGFR-TKI vs. EGFR-TKI Monotherapy in EGFR-Mutant NSCLC with Leptomeningeal Metastasis},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e12--e13},
doi = {10.1016/j.ijrobp.2026.06.682}
}
EUVIMED